Darzalex (daratumumab) Subcutaneous

daratumumab · Janssen Biotech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Darzalex (daratumumab) Subcutaneous, covering 2025-07-20 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: Study of SubQ Dara With Dose-Attenuated Bortezomib, Lenalidomide, Dexamethasone in Elderly NDMM [Phase 2]